Cargando…

Ion Channels in Pulmonary Hypertension: A Therapeutic Interest?

Pulmonary arterial hypertension (PAH) is a multifactorial and severe disease without curative therapies. PAH pathobiology involves altered pulmonary arterial tone, endothelial dysfunction, distal pulmonary vessel remodeling, and inflammation, which could all depend on ion channel activities (K(+), C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lambert, Mélanie, Capuano, Véronique, Olschewski, Andrea, Sabourin, Jessica, Nagaraj, Chandran, Girerd, Barbara, Weatherald, Jason, Humbert, Marc, Antigny, Fabrice
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214085/ https://www.ncbi.nlm.nih.gov/pubmed/30322215 http://dx.doi.org/10.3390/ijms19103162

Ejemplares similares

Implication of Potassium Channels in the Pathophysiology of Pulmonary Arterial Hypertension
por: Le Ribeuz, Hélène, et al.
Publicado: (2020)

Involvement of SUR2/Kir6.1 channel in the physiopathology of pulmonary arterial hypertension
por: Le Ribeuz, Hélène, et al.
Publicado: (2023)

Role of Ion Channels in the Development of Pulmonary Arterial Hypertension
por: Antigny, Fabrice
Publicado: (2022)

Role of Store-Operated Ca(2+) Entry in the Pulmonary Vascular Remodeling Occurring in Pulmonary Arterial Hypertension
por: Masson, Bastien, et al.
Publicado: (2021)

Sex and gender in pulmonary arterial hypertension
por: Cheron, Céline, et al.
Publicado: (2021)

Heritable pulmonary hypertension: from bench to bedside
por: Girerd, Barbara, et al.
Publicado: (2017)

Role of Ion Channel Remodeling in Endothelial Dysfunction Induced by Pulmonary Arterial Hypertension
por: Santos-Gomes, Joana, et al.
Publicado: (2022)

Illuminating the Importance of Pulmonary Arterial Compliance in Pulmonary Hypertension
por: Weatherald, Jason, et al.
Publicado: (2023)

Proteomic Analysis of KCNK3 Loss of Expression Identified Dysregulated Pathways in Pulmonary Vascular Cells
por: Le Ribeuz, Hélène, et al.
Publicado: (2020)

Pulmonary arterial hypertension registries: past, present and into the future
por: Weatherald, Jason, et al.
Publicado: (2019)

Screening for pulmonary arterial hypertension in systemic sclerosis
por: Weatherald, Jason, et al.
Publicado: (2019)

Pulmonary capillary haemangiomatosis: a distinct entity?
por: Weatherald, Jason, et al.
Publicado: (2020)

Precision medicine and personalising therapy in pulmonary hypertension: seeing the light from the dawn of a new era
por: Savale, Laurent, et al.
Publicado: (2018)

In vivo miR-138-5p inhibition alleviates monocrotaline-induced pulmonary hypertension and normalizes pulmonary KCNK3 and SLC45A3 expression
por: Le Ribeuz, Hélène, et al.
Publicado: (2020)

Pulmonary endothelial cell DNA methylation signature in pulmonary arterial hypertension
por: Hautefort, Aurélie, et al.
Publicado: (2017)

Revisiting the Large-Conductance Calcium-Activated Potassium (BKCa) Channels in the Pulmonary Circulation
por: Guntur, Divya, et al.
Publicado: (2021)

Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce de Résistance?
por: Weatherald, Jason, et al.
Publicado: (2021)

Potassium Channels in the Transition from Fetal to the Neonatal Pulmonary Circulation
por: Nagaraj, Chandran, et al.
Publicado: (2022)

Pulmonary hypertension associated with diazoxide: the SUR1 paradox
por: Montani, David, et al.
Publicado: (2023)

Seeing the Forest for the (Arterial) Tree: Vascular Pruning and the Chronic Obstructive Pulmonary Disease Pulmonary Vascular Phenotype
por: Weatherald, Jason, et al.
Publicado: (2019)

Specific Upregulation of TRPC1 and TRPC5 Channels by Mineralocorticoid Pathway in Adult Rat Ventricular Cardiomyocytes
por: Bartoli, Fiona, et al.
Publicado: (2019)

Management of Pulmonary Hypertension Due to Chronic Lung Disease
por: Sugarman, Jordan, et al.
Publicado: (2021)

Acute decompensated pulmonary hypertension
por: Savale, Laurent, et al.
Publicado: (2017)

The isobaric pulmonary arterial compliance in pulmonary hypertension
por: Chemla, Denis, et al.
Publicado: (2021)

Exertional dyspnoea in pulmonary arterial hypertension
por: Dumitrescu, Daniel, et al.
Publicado: (2017)

Right Ventricle Remodeling Metabolic Signature in Experimental Pulmonary Hypertension Models of Chronic Hypoxia and Monocrotaline Exposure
por: Hautbergue, Thaïs, et al.
Publicado: (2021)

Redox Regulation of Ion Channels in the Pulmonary Circulation
por: Olschewski, Andrea, et al.
Publicado: (2015)

Angiostatic Factors in the Pulmonary Endarterectomy Material from Chronic Thromboembolic Pulmonary Hypertension Patients Cause Endothelial Dysfunction
por: Zabini, Diana, et al.
Publicado: (2012)

Mortality trends in pulmonary arterial hypertension: Are we just spinning our wheels?
por: Zelt, Jason G. E., et al.
Publicado: (2022)

Rho-Kinase Inhibition Ameliorates Dasatinib-Induced Endothelial Dysfunction and Pulmonary Hypertension
por: Fazakas, Csilla, et al.
Publicado: (2018)

ERS International Congress, Madrid, 2019: highlights from the Pulmonary Vascular Diseases Assembly
por: Ramjug, Sheila, et al.
Publicado: (2020)

Lipidomics for diagnosis and prognosis of pulmonary hypertension
por: Bordag, Natalie, et al.
Publicado: (2023)

The SOCE Machinery: An Unbalanced Knowledge between Left and Right Ventricular Pathophysiology
por: Sabourin, Jessica, et al.
Publicado: (2022)

Pulmonary arterial hypertension secondary to adult-onset Still’s disease: Response to cyclosporine and sildenafil over 15 years of follow-up
por: Weatherald, Jason, et al.
Publicado: (2016)

Pulmonary arterial hypertension
por: Montani, David, et al.
Publicado: (2013)

Pulmonary hypertension associated with neurofibromatosis type 1
por: Jutant, Etienne-Marie, et al.
Publicado: (2018)

Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension
por: Girerd, Barbara, et al.
Publicado: (2010)

Ion channels as convergence points in the pathology of pulmonary arterial hypertension
por: Jouen-Tachoire, Thibault R. H., et al.
Publicado: (2021)

Sex and gender in lung health and disease: more than just Xs and Ys
por: Weatherald, Jason, et al.
Publicado: (2021)

Pulmonary Vascular Disease and Cardiopulmonary Exercise Testing
por: Laveneziana, Pierantonio, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8iqcbh85ah4gnrij6rp0li5ihr